[go: up one dir, main page]

RU2012124942A - MEANS OF NOOTROPIC IMPACT ON THE ORGANISM - Google Patents

MEANS OF NOOTROPIC IMPACT ON THE ORGANISM Download PDF

Info

Publication number
RU2012124942A
RU2012124942A RU2012124942/15A RU2012124942A RU2012124942A RU 2012124942 A RU2012124942 A RU 2012124942A RU 2012124942/15 A RU2012124942/15 A RU 2012124942/15A RU 2012124942 A RU2012124942 A RU 2012124942A RU 2012124942 A RU2012124942 A RU 2012124942A
Authority
RU
Russia
Prior art keywords
nootropic
organism
impact
proline
alanine
Prior art date
Application number
RU2012124942/15A
Other languages
Russian (ru)
Other versions
RU2517209C2 (en
Inventor
Александр Александрович Колобов
Григорий Валерьянович Никифорович
Алексей Николаевич Прусаков
Владимир Михайлович Шпень
Original Assignee
Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" filed Critical Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА"
Priority to RU2012124942/15A priority Critical patent/RU2517209C2/en
Publication of RU2012124942A publication Critical patent/RU2012124942A/en
Application granted granted Critical
Publication of RU2517209C2 publication Critical patent/RU2517209C2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)

Abstract

1. Средство, обладающее ноотропным воздействием на организм на основе циклических дипептидов, содержащее последовательность пролин-аланин.2. Средство по п.1, представляющее собой циклический дипептид, содержащее последовательность пролин-D-аланин.1. A tool with a nootropic effect on the body based on cyclic dipeptides containing the proline-alanine sequence. 2. The tool according to claim 1, which is a cyclic dipeptide containing the sequence of proline-D-alanine.

Claims (2)

1. Средство, обладающее ноотропным воздействием на организм на основе циклических дипептидов, содержащее последовательность пролин-аланин.1. The tool has a nootropic effect on the body based on cyclic dipeptides containing the proline-alanine sequence. 2. Средство по п.1, представляющее собой циклический дипептид, содержащее последовательность пролин-D-аланин. 2. The tool according to claim 1, which is a cyclic dipeptide containing the sequence of proline-D-alanine.
RU2012124942/15A 2012-06-07 2012-06-07 Medication, which produces nootropic action on organism RU2517209C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012124942/15A RU2517209C2 (en) 2012-06-07 2012-06-07 Medication, which produces nootropic action on organism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012124942/15A RU2517209C2 (en) 2012-06-07 2012-06-07 Medication, which produces nootropic action on organism

Publications (2)

Publication Number Publication Date
RU2012124942A true RU2012124942A (en) 2013-12-20
RU2517209C2 RU2517209C2 (en) 2014-05-27

Family

ID=49784675

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012124942/15A RU2517209C2 (en) 2012-06-07 2012-06-07 Medication, which produces nootropic action on organism

Country Status (1)

Country Link
RU (1) RU2517209C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2694233C2 (en) * 2017-10-13 2019-07-10 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Agent having nootropic effect on body

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232798B2 (en) * 2001-11-13 2007-06-19 Tran Loi H Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
US8791117B2 (en) * 2003-09-03 2014-07-29 Neuren Pharmaceuticals Limited Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
RU2394836C2 (en) * 2008-09-12 2010-07-20 Ибмед Холдингс Лимитед Peptide having neurotropic activity

Also Published As

Publication number Publication date
RU2517209C2 (en) 2014-05-27

Similar Documents

Publication Publication Date Title
CY1124431T1 (en) SYRINGE
SG10201900948PA (en) Modified nucleotide linkers
UA113643C2 (en) N-CYCLYLAMIDES AS NEMATOCIDES
WO2014194034A3 (en) Novel metalloproteases
UY34484A (en) BENZOTIENILO-PIRROLOTRIAZINAS DISUSTITUIDAS AND ITS USES
EA201390081A1 (en) DEUTERED N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLOR-1-METHYL-2-OXOHINOLIN-3-CARBOXAMIDE, ITS SALT AND THEIR APPLICATION
EA033398B1 (en) Stiff polypropylene composition suitable for primerless painting
AR095977A1 (en) A PROCEDURE TO INCREASE THE FORMATION OF PYROGLUTAMIC ACID OF A PROTEIN
EA201591349A1 (en) METHOD OF OBTAINING VORTIOXETIN
CR20150084A (en) 2-OXO-2,3-DIHYDRO-INDOLES
EA201600304A1 (en) APPLICATION OF SUBSTITUTED DIHYDROOXINDOLYL SULPHONAMIDES OR THEIR SALTS TO ENHANCE PLANT TOLERANCE TO STRESS
IN2015DN03307A (en)
UY34629A (en) Ubicuitin activating enzyme pyrazolopyrimidinyl inhibitors
HN2015000698S1 (en) MOTORCYCLE
EA201491300A1 (en) COMPOSITION FOR BODY APPLICATION WITH IMPROVED STABILITY
EA201300733A1 (en) RECOMBINANT MICOBACTERIA AS A VACCINE
AR093738A1 (en) SOLID FORMS INCLUDING INHIBITORS OF NS5A HCV, ITS COMPOSITIONS AND ITS USES
CL2018001080A1 (en) Leaching in batteries.
MY184391A (en) Microorganism having improved intracellular energy level and method for producing l-amino acid using same
BR112014027230A2 (en) flashlight with integrated clamp
NZ717192A (en) Anti-inflammatory tripeptides
RU2012124942A (en) MEANS OF NOOTROPIC IMPACT ON THE ORGANISM
EA201691112A1 (en) FORMATION OF EX VITO ANTIBODIES
BR112015023730A2 (en) use of sedoeptulose as a nutritional supplement
CY1125162T1 (en) SYRINGE

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140608

NF4A Reinstatement of patent

Effective date: 20160127

PC41 Official registration of the transfer of exclusive right

Effective date: 20160421

QB4A Licence on use of patent

Free format text: LICENCE FORMERLY AGREED ON 20211230

Effective date: 20211230